GENERIC NAME OF MEDICINAL PRODUCT:

A. Neostigmine Methylsulphate Injection IP 0.5mg/ml
B. Neostigmine Methylsulphate Injection IP 2.5mg/5ml

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A. Neostigmine Methylsulphate Injection IP 0.5mg/ml
Each ml contains:
Neostigmine Methylsulphate IP……..0.5mg
Water for Injection IP……………………..q.s

B. Neostigmine Methylsulphate Injection IP 2.5mg/5ml
Each ml contains:
Neostigmine Methylsulphate IP……..0.5mg
Water for Injection IP……………………..q.s

THERAPEUTIC INDICATION:

Neostigmine methylsulphate injection is an anticholinesterase agent used to treat myasthenia gravis, postoperative distention and urinary retention, and to reverse effects of non-depolarizing neuromuscular blocking agents after surgery.

DIRECTION OF USE:

For I.M. / Slow I.V. / S.C. use.
Neostigmine should be administered by trained healthcare providers familiar with the use, actions, characteristics, and complications of neuromuscular blocking agents (NMBA) and neuromuscular block reversal agents.
Prior to Neostigmine Methylsulphate Injection administration and up until complete recovery of normal ventilation, the patient should be well ventilated and a patent airway maintained.

CAUTION AND SCHEDULE:

CAUTION: The injection should not be used if it contains visible particulate matter.
KEEP OUT OF REACH AND SIGHT OF CHILDREN.
FLIP-OFF SEAL IS PROVIDED FOR TAMPER EVIDENCE.
SCHEDULE: SCHEDULE 'H PRESCRIPTION DRUG-CAUTION Not to be sold by retail without the prescription of a Registered Medical Practitioner

STORAGE AND DOSAGE:

STORAGE: Store below 25°C. Protect from light. Do not freeze.
DOSAGE: As directed by the Physician.

Neostigmine Methylsulphate Injection IP 2.5mg/5ml Technical Specification:

Product Name:Neostigmine Methylsulphate Injection IP
Brand Name:Generic
Strength:0.5mg/ml,  2.5mg/5ml
Dosage Form:Liquid Injection
Packing:Snap-off Ampoules (Pack of 5 and 10)
Route of Administration:For I.M. / Slow I.V. / S.C. use
Pack Insert/Leaflet:PIL (Patient Information Leaflet)
Documents:COA, MOA, Product Permission, Stability Studies, GMP
Therapeutic use:Acetylcholinesterase Inhibitors, Peripheral
Indication: Neostigmine methylsulphate injection is an anticholinesterase agent used to treat myasthenia gravis, postoperative distention and urinary retention, and to reverse effects of non-depolarizing neuromuscular blocking agents after surgery.
Storage:Store below 25°C. Protect from light. Do not freeze.

GENERIC NAME OF MEDICINAL PRODUCT:

  • Neostigmine Methylsulphate Injection IP 2.5mg/5ml

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Neostigmine Methylsulphate Injection IP 2.5mg/5ml
    Each ml contains:
    Neostigmine Methylsulphate IP……..0.5mg
    Water for Injection IP……………………..q.s

THERAPEUTIC INDICATION:

Neostigmine methylsulphate injection is an anticholinesterase agent used to treat myasthenia gravis, postoperative distention and urinary retention, and to reverse effects of non-depolarizing neuromuscular blocking agents after surgery.

DIRECTION OF USE:

For I.M. / Slow I.V. / S.C. use.
Neostigmine should be administered by trained healthcare providers familiar with the use, actions, characteristics, and complications of neuromuscular blocking agents (NMBA) and neuromuscular block reversal agents.
Prior to Neostigmine Methylsulphate Injection administration and up until complete recovery of normal ventilation, the patient should be well ventilated and a patent airway maintained.

CAUTION AND SCHEDULE:

CAUTION: The injection should not be used if it contains visible particulate matter.
KEEP OUT OF REACH AND SIGHT OF CHILDREN.
FLIP-OFF SEAL IS PROVIDED FOR TAMPER EVIDENCE.

SCHEDULE: SCHEDULE ‘H PRESCRIPTION DRUG-CAUTION Not to be sold by retail without the prescription of a Registered Medical Practitioner

STORAGE AND DOSAGE:

STORAGE: Store below 25°C. Protect from light. Do not freeze.

DOSAGE: As directed by the Physician.